blinatumomab
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
blinatumomab
Jul 25, 2024, 21:25 |
Blog
Elad Sharon: Another win for patients with ALL
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared on X: "Another win for…
Jul 13, 2024, 14:46 |
Blog
14-year-old Sasha with lymphoblastic leukemia needs our help - City of Smile Charitable Foundation
City of Smile Charitable Foundation shared on LinkedIn: …
Jun 21, 2024, 09:47 |
Blog
Blinatumomab alternating with LIC in older adults with newly diagnosed B-ALL - ALL Hub
ALL Hub shared a post on X: "CONGRESS | POSTER | EHA2024 | Elias Jabbour…
Jun 15, 2024, 13:31 |
Insight
Hagop Kantarjian: Chemo-free regimens are highly effective in Ph+ALL
Hagop Kantarjian shared on X/Twitter: "Chemo-free regimens (TKIs-blinatumomab) highly effective in Ph+ALL; may replace intensive chemotherapy…
May 15, 2024, 14:47 |
Drugs
Hagop Kantarjian: New research is expanding inotuzumab use into frontline, for MRD+, and in combination with blinatumomab
Nicholas Short, Associate Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Apr 16, 2024, 01:37 |
Insight
Talha Badar: A brief overview on MLL gene re-arranged AL in this thread
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a thread on X/Twitter: "Weekend review: MLL- rearrange…
Feb 3, 2024, 13:53 |
Drugs
Talha Badar: Upfront immunotherapy with or without chemotherapy for precursor B-cell ALL
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Upfront immunotherapy +/-…
Jan 18, 2024, 10:38 |
Insight
Nicola Gökbuget: Time to acknowledge the very successful presentations of the German Multicenter Study Group for Adult ALL
Nicola Gökbuget, Head of Clinical Trial Center at Goethe University Hospital, posted on LinkedIn: "The…
Jan 16, 2024, 11:37 |
Insight
Jayastu Senapati: Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Dec 15, 2023, 06:27 |
Blog
Jayastu Senapati: Check out our poster on display at ASH23
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Dec 8, 2023, 12:47 |
Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Nov 17, 2023, 16:57 |
Drugs
Joseph Lasky: Congratulations to my colleagues on their tireless research and work on this important subject
Joseph Lasky, Medical Director at Cure 4 The Kids Foundation, posted on LinkedIn. "I'm excited…
Oct 15, 2023, 18:06 |
Blog
Adam Esbenshade: Outstanding talk by Caitlyn Duffy from St. Jude at SIOP ALL session
Quoting Adam Esbenshade, Associate Professor of Pediatrics at the Vanderbilt University Medical Center, on X/Twitter:…
Sep 7, 2023, 19:44 |
Insight
Iyad Sultan: A Mixed Bag in Pediatric B-ALL Treatment!
Quoting Iyad Sultan, Chairman and Professor, Department of Pediatrics, King Hussein Cancer Center and a…
May 18, 2023, 14:56 |
Drugs
Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy
NEW: Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy showed promising activity in…
All:
15
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube